TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Swedish Orphan Biovitrum AS
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
31,140
|
17,611
|
17,861 |
| Financial expenses |
7
|
1
|
0 |
| Earnings before taxes |
9,427
|
5,080
|
5,354 |
| Total assets |
41,213
|
29,440
|
25,502 |
| Current assets |
41,198
|
29,397
|
25,422 |
| Current liabilities |
8,194
|
3,757
|
3,769 |
| Equity capital |
33,020
|
25,682
|
21,733 |
| - share capital |
100
|
100
|
100 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
80.1%
|
87.2%
|
85.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
30.3%
|
28.8%
|
30.0% |
| Return on assets (ROA) |
22.9%
|
17.3%
|
21.0% |
| Current ratio |
502.8%
|
782.5%
|
674.5% |
| Return on equity (ROE) |
28.5%
|
19.8%
|
24.6% |
| Change turnover |
13,529
|
-250
|
-809 |
| Change turnover % |
77%
|
-1%
|
-4% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.